从症状疗法到对神经通道疾病的疾病修改方法
Giorgia Dinoi1, Ileana Canfora1, Daniela D'Agnano2
1Department of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", Via Orabona 4, 70125 Bari, Italy.
International journal of molecular sciences
|January 10, 2026
概括
神经元通道中的遗传变异会导致神经系统疾病,如发育性和性脑病变 (DEEs). 新的精确疗法正在出现,以改善控制和解决发育问题,超越传统的症状治疗.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经道基因变异是各种神经系统疾病的基础,特别是发育性和性脑病变 (DEE).
- 这些疾病表现出显著的遗传和表型变异性,经常伴随着对常规抗发作药物的耐药性.
- 目前的治疗方法,主要是症状多疗法,有效性有限,无法解决潜在的发育障碍.
研究的目的:
- 审查与通道基因变异有关的神经系统疾病治疗的最新进展.
- 要突出从症状管理转向针对性,精确治疗的转变.
- 讨论新兴策略及其在临床前和临床环境中的潜力.
主要方法:
- 对与道相关的神经疾病的已批准和正在研究的治疗方法的文献综述.
- 分析新兴的治疗策略,包括反感性寡核酸,基因疗法和小分子调节器.
- 检查药理学药物,如芬弗卢拉胺,斯蒂醇和大麻二醇的特定条件,如SCN1A相关的德拉维特综合征.
主要成果:
- 通道基因变异可能导致损失,增益或混合功能效应,使治疗选择复杂化.
- 针对SCN基因表达和功能的新兴疗法在临床前模型和早期临床研究中显示出有前途.
- 某些非通道向药物已被确立为特定疾病的治疗方法,如SCN1A相关的德拉维特综合征.
结论:
- 显著需要新的治疗方法,超越目前对DEE和相关疾病的症状治疗方法.
- 精密疗法,包括基因调制和向小分子,代表了一个有希望的前沿.
- 该领域正在向针对特定遗传基础和通道变异的功能后果的个性化治疗过渡.
相关概念视频
01:08Antiepileptic Drugs: Sodium Channel Blockers
1.6K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.6K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
806
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
806
01:22Alzheimer's Disease: Treatment
806
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
806
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
2.8K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.8K
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.8K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.8K